Skip to main content

Patient Reported Outcomes Investigation Following Initiation of Drug Therapy with Entresto (Sacubitril/Valsartan) in Heart Failure

Research Grant
Duke Scholars

Administered By

Institutes and Centers

Awarded By

Novartis Pharmaceuticals Corporation

Start Date

May 25, 2018

End Date

December 31, 2019
 

Administered By

Institutes and Centers

Awarded By

Novartis Pharmaceuticals Corporation

Start Date

May 25, 2018

End Date

December 31, 2019